These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17906080)

  • 1. Inflammation: friend or foe of muscle remodelling in COPD?
    Langen RC; Schols AM
    Eur Respir J; 2007 Oct; 30(4):605-7. PubMed ID: 17906080
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD.
    Vogiatzis I; Simoes DC; Stratakos G; Kourepini E; Terzis G; Manta P; Athanasopoulos D; Roussos C; Wagner PD; Zakynthinos S
    Eur Respir J; 2010 Aug; 36(2):301-10. PubMed ID: 20110400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway inflammation in COPD: friend or foe?
    Brusasco V; Crimi E; Pellegrino R
    Am J Respir Crit Care Med; 2007 Sep; 176(5):425-6. PubMed ID: 17715379
    [No Abstract]   [Full Text] [Related]  

  • 4. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease.
    Koziol-White CJ; Panettieri RA
    Immunol Rev; 2011 Jul; 242(1):178-85. PubMed ID: 21682745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
    Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
    Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
    Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic inflammation in chronic obstructive pulmonary disease.
    Wouters EF
    Proc Am Thorac Soc; 2005; 2(1):26-33. PubMed ID: 16113466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anemia in COPD].
    Roşu R; Popescu A; Mihălţan F
    Pneumologia; 2006; 55(3):113-8. PubMed ID: 17144480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine: a novel regulator of airway smooth muscle remodelling?
    Gosens R; Zaagsma J; Grootte Bromhaar M; Nelemans A; Meurs H
    Eur J Pharmacol; 2004 Oct; 500(1-3):193-201. PubMed ID: 15464033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease.
    Slats AM; Janssen K; van Schadewijk A; van der Plas DT; Schot R; van den Aardweg JG; de Jongste JC; Hiemstra PS; Mauad T; Rabe KF; Sterk PJ
    Am J Respir Crit Care Med; 2007 Jul; 176(2):121-8. PubMed ID: 17379851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease.
    Jeffery PK
    Proc Am Thorac Soc; 2004; 1(3):176-83. PubMed ID: 16113432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K
    Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential anti-inflammatory effect of exercise in chronic obstructive pulmonary disease.
    van der Vlist J; Janssen TW
    Respiration; 2010; 79(2):160-74. PubMed ID: 19672044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of recombinant human tumor necrosis factor-Fc on pulmonary function in a rat model of chronic obstructive pulmonary disease].
    Zhang C; Chen P; Cai S; Chen JB; Wu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):432-6. PubMed ID: 17673016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
    Antoniu SA
    Biomarkers; 2010 Mar; 15(2):97-103. PubMed ID: 19929747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients.
    Casadevall C; Coronell C; Ramírez-Sarmiento AL; Martínez-Llorens J; Barreiro E; Orozco-Levi M; Gea J
    Eur Respir J; 2007 Oct; 30(4):701-7. PubMed ID: 17626109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD: a multifactorial systemic disease.
    Huertas A; Palange P
    Ther Adv Respir Dis; 2011 Jun; 5(3):217-24. PubMed ID: 21429981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD.
    Liesker JJ; Ten Hacken NH; Rutgers SR; Zeinstra-Smith M; Postma DS; Timens W
    Respir Med; 2007 May; 101(5):882-7. PubMed ID: 17097865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease].
    He P
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2089-91. PubMed ID: 19080465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.